Related Experiment Video
Updated: Jun 20, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Rippling muscle disease and cardiomyopathy associated with a mutation in the CAV3 gene
Michela Catteruccia1, Tommaso Sanna, Filippo Maria Santorelli
1Department of Neuroscience, Institute of Neurology, Catholic University, Largo Agostino Gemelli 8, 00168 Rome, Italy.
Abstract:
Caveolin-3, the myocyte-specific isoform of caveolins, is preferentially expressed in skeletal, cardiac and smooth muscles. Mutations in the CAV3 gene cause clinically heterogeneous neuromuscular disorders, including rippling muscle disease, or cardiopathies. The same mutation may lead to different phenotypes, but cardiac and muscle involvement rarely coexists suggesting that the molecular network acting with caveolin-3 in skeletal muscle and heart may differ. Here we describe an Italian family (a father and his two sons) with clinical and neurophysiological features of rippling muscle disease and heart involvement characterized by atrio-ventricular conduction defects and dilated cardiomyopathy. Muscle biopsy showed loss of caveolin-3 immunosignal. Molecular studies identified the p.A46V mutation in CAV3 previously reported in a German family with autosomal dominant rippling muscle disease and sudden death in few individuals. We suggest that cardiac dysfunction in myopathic patients with CAV3 mutations may be underestimated and recommend a more thorough evaluation for the presence of cardiomyopathy and potentially lethal arrhythmias.
Insights
Mutations in the CAV3 gene cause rippling muscle disease and heart problems. This study identified the p.A46V mutation in a family, highlighting the need for cardiac evaluation in myopathic patients.
Area of Science:
- Genetics
- Molecular Biology
- Cardiology
Background:
- Caveolin-3 (encoded by CAV3) is crucial in muscle and heart function.
- CAV3 mutations cause diverse neuromuscular and cardiac disorders.
- Phenotypic variability suggests different molecular interactions in skeletal muscle and heart.
Purpose of the Study:
- To investigate a family with rippling muscle disease and cardiac involvement.
- To identify the genetic cause of the observed phenotypes.
- To emphasize the importance of cardiac assessment in CAV3-related myopathies.
Main Methods:
- Clinical and neurophysiological evaluation.
- Muscle biopsy with caveolin-3 immunosignal assessment.
- Molecular genetic analysis of the CAV3 gene.
Main Results:
- An Italian family presented with rippling muscle disease and cardiac issues (conduction defects, dilated cardiomyopathy).
- Muscle biopsies revealed a loss of caveolin-3.
- The p.A46V mutation in CAV3 was identified, previously linked to autosomal dominant rippling muscle disease.
Conclusions:
- The p.A46V CAV3 mutation can cause both skeletal muscle and cardiac dysfunction.
- Cardiac involvement in CAV3-related myopathies may be underdiagnosed.
- Thorough cardiac evaluation is recommended for patients with CAV3 mutations to detect potentially lethal arrhythmias and cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Satellite Stem Cells and Muscular Dystrophy

